Larimar Therapeutics Inc. buy BiotechBee
Start price
28.09.25
/
70%
€4.50
Target price
31.08.27
€12.00
Performance (%)
-31.56%
End price
21.11.25
€3.08
Summary
This prediction ended on 21.11.25 with a price of €3.08. Massive losses of -31.56% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Larimar Therapeutics Inc. | 8.974% | 8.974% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zafgen Inc. diskutieren
Buy mit Kursziel 12,0
In the thread Trading Zafgen Inc.
Buy beendet
Stopped prediction by BiotechBee for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.34
14.09.25
14.09.25
€7.00
31.08.27
31.08.27
1.20%
15.09.25
15.09.25
Could be very worthwhile Investment >20% year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.00
14.12.24
14.12.24
€9.00
31.10.26
31.10.26
-39.67%
16.12.24
16.12.24
Could be very worthwhile Investment >20% year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.00
04.02.24
04.02.24
€7.00
31.03.26
31.03.26
0.00%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.18
20.09.22
20.09.22
€7.00
31.08.25
31.08.25
32.08%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year

